Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Litmore Capital
investment firm
About
Litmore Capital
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
2
0
Litmore Capital has made 2 investments. Their most recent investment was on
Feb 21, 2017, when Bristol Myers Squibb raised $80M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 21, 2017
Bristol Myers Squibb
|
Post-IPO Equity | $80M | Biotechnology | — |
|
Nov 1, 2016
Biohaven Pharmaceutical
|
Series Unknown | $80M | Biotechnology | — |
Exits
Litmore Capital has had 2 exits. Litmore Capital most notable exits include Biohaven Pharmaceutical , Bristol Myers Squibb
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| May 5, 2017 | Biohaven Pharmaceutical | M&A | Biotechnology | Detail |
| Jan 1, 1972 | Bristol Myers Squibb | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
